Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-28
DOI
10.3389/fimmu.2021.773983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Cytokines in Experimental and Human Visceral Leishmaniasis
- (2021) Mukesh Samant et al. Frontiers in Cellular and Infection Microbiology
- High levels of anti-Leishmania IgG3 and low CD4+ T cells count were associated with relapses in visceral leishmaniasis
- (2021) Renata Caetano Kuschnir et al. BMC INFECTIOUS DISEASES
- CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers
- (2020) Alessandro Marins-Dos-Santos et al. PLoS Neglected Tropical Diseases
- IFN-γ+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis
- (2020) Sunita Yadav et al. CELLULAR IMMUNOLOGY
- Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
- (2019) Alti Dayakar et al. Frontiers in Immunology
- Functional aspects of T cell diversity in visceral leishmaniasis
- (2019) Junaid Jibran Jawed et al. BIOMEDICINE & PHARMACOTHERAPY
- A molecular signature for CD8 + T cells from visceral leishmaniasis patients
- (2019) Bhawana Singh et al. PARASITE IMMUNOLOGY
- Decreased CD4+CD8low T cells in early HIV infection are associated with rapid disease progression
- (2019) Zi-Dan Ding et al. CYTOKINE
- CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection
- (2018) João F. Rodrigues-Neto et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis
- (2018) Neetu Singh et al. PLoS One
- Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis
- (2018) Abdus Sabur et al. Frontiers in Immunology
- Chemotherapeutics of visceral leishmaniasis: present and future developments
- (2017) SHYAM SUNDAR et al. PARASITOLOGY
- Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance
- (2017) Théo Araújo-Santos et al. Scientific Reports
- Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
- (2017) Gustavo Adolfo Sierra Romero et al. PLoS Neglected Tropical Diseases
- F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis
- (2017) Eugenia Carrillo et al. Frontiers in Immunology
- Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
- (2017) Micheli Luize Barbosa Santos et al. Frontiers in Immunology
- The Surface Area Deviation of the Euclidean Ball and a Polytope
- (2016) Steven D. Hoehner et al. JOURNAL OF THEORETICAL PROBABILITY
- Regulation of immunity during visceral Leishmania infection
- (2016) Vasco Rodrigues et al. Parasites & Vectors
- The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14
- (2016) Priscila L. dos Santos et al. PLoS Neglected Tropical Diseases
- Cutaneous Leishmaniasis Vaccination: A Matter of Quality
- (2016) Paula Mello De Luca et al. Frontiers in Immunology
- Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis
- (2015) Elisangela Oliveira Freitas et al. PLoS Neglected Tropical Diseases
- The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy
- (2015) Ines Lakhal-Naouar et al. PLoS Neglected Tropical Diseases
- Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
- (2014) Himanshu Kaushal et al. BMC INFECTIOUS DISEASES
- Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis
- (2014) Rajiv Kumar et al. PLoS Neglected Tropical Diseases
- Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection
- (2014) Dirlei Nico et al. Frontiers in Immunology
- CD8 T Cell Exhaustion in Human Visceral Leishmaniasis
- (2013) Shalini Gautam et al. JOURNAL OF INFECTIOUS DISEASES
- CD8low T-cell subpopulation is increased in patients with chronic hepatitis B virus infection
- (2013) Lichen Ouyang et al. MOLECULAR IMMUNOLOGY
- Serum cytokines associated with severity and complications of kala-azar
- (2013) Dorcas L Costa et al. Pathogens and Global Health
- Vaccine prospects of killed but metabolically activeLeishmaniaagainst visceral leishmaniasis
- (2012) Amrita Das et al. Expert Review of Vaccines
- Complications infectieuses liées au traitement par anti-TNFα : à propos de deux cas de leishmaniose
- (2012) E. Bousquet et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Regulatory T Cells Suppress T Cell Activation at the Pathologic Site of Human Visceral Leishmaniasis
- (2012) Ambak K. Rai et al. PLoS One
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- CD8+ T Cells in Leishmania Infections: Friends or Foes?
- (2012) Simona Stäger et al. Frontiers in Immunology
- Multifunctional CD4+T cells in patients with American cutaneous leishmaniasis
- (2011) A. B. B. Macedo et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
- (2011) Yasuyuki Goto et al. Clinical and Vaccine Immunology
- Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis
- (2011) Medhavi Sudarshan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quantification of Parasite Load in Clinical Samples of Leishmaniasis Patients: IL-10 Level Correlates with Parasite Load in Visceral Leishmaniasis
- (2010) Sandeep Verma et al. PLoS One
- Immunoactivation and immunopathogeny during active visceral leishmaniasis
- (2010) Hiro Goto et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
- (2010) Smriti Mondal et al. PLoS Neglected Tropical Diseases
- Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?
- (2008) J. Clarencio et al. INTERNATIONAL IMMUNOLOGY
- Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate
- (2008) Ioannis Venizelos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started